GNR-055

GNR-055 · AO Generium

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for GNR-055, covering 2024-07-03 to 2025-07-30. Get the full timeline:

Most recent: Clinical Trial Update: A Multi-cohort Study of Safety, Efficacy, PK and PD of GNR-055 in Patients With Mucopolysaccharidosis Type II [Phase 2, Phase 3]

See pricing